Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort study.

Staessen JA, Wendt R, Yu YL, Kalbitz S, Thijs L, Siwy J, Raad J, Metzger J, Neuhaus B, Papkalla A, von der Leyen H, Mebazaa A, Dudoignon E, Spasovski G, Milenkova M, Canevska-Taneska A, Salgueira Lazo M, Psichogiou M, Rajzer MW, Fuławka Ł, Dzitkowska-Zabielska M, Weiss G, Feldt T, Stegemann M, Normark J, Zoufaly A, Schmiedel S, Seilmaier M, Rumpf B, Banasik M, Krajewska M, Catanese L, Rupprecht HD, Czerwieńska B, Peters B, Nilsson Å, Rothfuss K, Lübbert C, Mischak H, Beige J, CRIT-CoV-U investigators

Open source

DOI
10.1016/s2589-7500(22)00150-9
Published
2022 Oct
Container
The Lancet. Digital health
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2589-7500-22-00150-9,
  title = {Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort study.},
  author = {Staessen JA and Wendt R and Yu YL and Kalbitz S and Thijs L and Siwy J and Raad J and Metzger J and Neuhaus B and Papkalla A and von der Leyen H and Mebazaa A and Dudoignon E and Spasovski G and Milenkova M and Canevska-Taneska A and Salgueira Lazo M and Psichogiou M and Rajzer MW and Fuławka Ł and Dzitkowska-Zabielska M and Weiss G and Feldt T and Stegemann M and Normark J and Zoufaly A and Schmiedel S and Seilmaier M and Rumpf B and Banasik M and Krajewska M and Catanese L and Rupprecht HD and Czerwieńska B and Peters B and Nilsson Å and Rothfuss K and Lübbert C and Mischak H and Beige J and CRIT-CoV-U investigators},
  year = {2022},
  journal = {The Lancet. Digital health},
  doi = {10.1016/s2589-7500(22)00150-9},
  url = {https://doi.org/10.1016/s2589-7500(22)00150-9}
}

RIS

TY  - JOUR
TI  - Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort study.
AU  - Staessen JA
AU  - Wendt R
AU  - Yu YL
AU  - Kalbitz S
AU  - Thijs L
AU  - Siwy J
AU  - Raad J
AU  - Metzger J
AU  - Neuhaus B
AU  - Papkalla A
AU  - von der Leyen H
AU  - Mebazaa A
AU  - Dudoignon E
AU  - Spasovski G
AU  - Milenkova M
AU  - Canevska-Taneska A
AU  - Salgueira Lazo M
AU  - Psichogiou M
AU  - Rajzer MW
AU  - Fuławka Ł
AU  - Dzitkowska-Zabielska M
AU  - Weiss G
AU  - Feldt T
AU  - Stegemann M
AU  - Normark J
AU  - Zoufaly A
AU  - Schmiedel S
AU  - Seilmaier M
AU  - Rumpf B
AU  - Banasik M
AU  - Krajewska M
AU  - Catanese L
AU  - Rupprecht HD
AU  - Czerwieńska B
AU  - Peters B
AU  - Nilsson Å
AU  - Rothfuss K
AU  - Lübbert C
AU  - Mischak H
AU  - Beige J
AU  - CRIT-CoV-U investigators
PY  - 2022
JO  - The Lancet. Digital health
DO  - 10.1016/s2589-7500(22)00150-9
UR  - https://doi.org/10.1016/s2589-7500(22)00150-9
ER  -

APA

JA, S., R, W., YL, Y., S, K., L, T., J, S., J, R., J, M., B, N., A, P., H, V. D. L., A, M., E, D., G, S., M, M., A, C., M, S. L., M, P., MW, R., Ł, F., M, D., G, W., T, F., M, S., J, N., A, Z., S, S., M, S., B, R., M, B., M, K., L, C., HD, R., B, C., B, P., Å, N., K, R., C, L., H, M., J, B., & investigators, C. (2022). Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort study.. The Lancet. Digital health. https://doi.org/10.1016/s2589-7500(22)00150-9

Source records